Publication | Open Access

Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma

Dendritic Cell ImmunotherapyTumor ImmunologyPancreatic CancerCancer ImmunosurveillanceMedicineMurine ModelImmunologyImmune Checkpoint InhibitorPancreatic CarcinomaImmunotherapyOncologyRadiation OncologyTumor Microenvironment